Targeting Skeletal Muscle Melatonin-MT2 Signaling to Attenuate the Obesity-Cancer Axis: A Metabolic Perspective
BIOCELL · 2026 · 50 (8) · 1-10
DOI: 10.32604/biocell.2026.079591 ↗Kurz gefasst
Fachartikel in der Zeitschrift BIOCELL, 2026. Verfasst von Mihaela Jurdana und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Obesity and metabolic syndrome promote malignancies through chronic inflammation and sustained activation of insulin and insulin-like growth factor-1 (IGF-1) signaling. Skeletal muscle is central to this tumor-promoting milieu because it governs insulin-stimulated glucose disposal, lipid oxidation, and endocrine crosstalk. This narrative review explores whether melatonin signaling in skeletal muscle, particularly via melatonin receptor 2 (MT2), represents a modifiable node within the obesity–cancer axis. Experimental evidence indicates that melatonin activates MT2-linked Gi/o and calcium-sensitive pathways converging on phosphoinositide 3-kinase–protein kinase B (PI3K–Akt), extracellular signal-regulated kinases (ERK), and calcium/calmodulin-dependent protein kinase II–adenosine monophosphate-activated protein kinase–peroxisome proliferator-activated receptor gamma coactivator 1-alpha (CaMKII–AMPK–PGC-1α) signaling. These pathways enhance insulin sensitivity, mitochondrial function, and lipid partitioning while reducing myosteatosis and cellular stress. By improving muscle quality, melatonin may lower systemic insulin and IGF-1 drive and inflammatory adipokine tone that fuel tumor-promoting PI3K–Akt–mammalian target of rapamycin (mTOR) signaling. However, human evidence remains limited and timing-dependent. Melatonin exposure in the fed state or near carbohydrate intake may worsen glycemia, particularly in carriers of melatonin receptor 1B (MTNR1B) risk alleles. Chronobiology-informed, genotype-guided trials with detailed muscle phenotyping and cancer-relevant endpoints are warranted.
Zitieren
APA
Jurdana, M., & Ziberna, L. (2026). Targeting Skeletal Muscle Melatonin-MT2 Signaling to Attenuate the Obesity-Cancer Axis: A Metabolic Perspective. BIOCELL, 50(8), 1-10. https://doi.org/10.32604/biocell.2026.079591
Vancouver
Jurdana M, Ziberna L. Targeting Skeletal Muscle Melatonin-MT2 Signaling to Attenuate the Obesity-Cancer Axis: A Metabolic Perspective. BIOCELL. 2026;50(8):1-10. doi:10.32604/biocell.2026.079591
BibTeX
@article{Jurdana2026,
author = {Jurdana, Mihaela and Ziberna, Lovro},
title = {Targeting Skeletal Muscle Melatonin-MT2 Signaling to Attenuate the Obesity-Cancer Axis: A Metabolic Perspective},
journal = {BIOCELL},
year = {2026},
volume = {50},
number = {8},
pages = {1--10},
doi = {10.32604/biocell.2026.079591}
}
EUVIMED